ABUS Forecast



Bearish<—>Bullish



80% Confidence




Bullish Case: ABUS's advancements in RNAi therapeutics, along with potential favorable legal outcomes, suggest significant upside, particularly if trial results align positively. Investors bullish on biotech could see ABUS as undervalued.




Bearish Case: High implied volatility signals market skepticism. The volatile history and ongoing legal risks may amplify downside risk, especially if trial results or legal outcomes disappoint.




Potential Outcomes:
  • Positive trial results: 30% chance, significant price rise.
  • Favorable patent litigation: 40% chance, moderate increase.
  • Negative legal/trial results: 30% chance, substantial drop.



March 22, 2025


Arbutus Biopharma Forecast

ABUS        Arbutus Biopharma











Correlated Assets

Assets that tend to move strongly with ABUS



ZETA Forecast + Options Trading Strategies   ZETA  Zeta Global Holdings Corp (0.89)


PTGX Forecast + Options Trading Strategies   PTGX  Protagonist Therapeutics (0.83)


FE Forecast + Options Trading Strategies   FE  Firstenergy (0.82)


INSG Forecast + Options Trading Strategies   INSG  Inseego (0.8)


SO Forecast + Options Trading Strategies   SO  Southern (0.79)



Uncorrelated Assets

Assets with little price relationship to ABUS



NWL Forecast + Options Trading Strategies   NWL  Newell Brands (-0.0)


AMZN Forecast + Options Trading Strategies   AMZN  Amazon.com (0.0)


BCE Forecast + Options Trading Strategies   BCE  BCE (0.01)


CG Forecast + Options Trading Strategies   CG  Carlyle (-0.01)


HIMX Forecast + Options Trading Strategies   HIMX  Himax (-0.02)



Anticorrelated Assets

Assets that tend to move strongly against ABUS



WST Forecast + Options Trading Strategies   WST  West Pharmaceutical Services (-0.72)


CRSR Forecast + Options Trading Strategies   CRSR  Corsair Gaming (-0.74)


TDOC Forecast + Options Trading Strategies   TDOC  Teladoc Health (-0.74)


BBWI Forecast + Options Trading Strategies   BBWI  Bath & Body Works (-0.82)


LABD Forecast + Options Trading Strategies   LABD  Direxion Daily S&P Biotech Bear 3X Shares (-0.86)









Become a more profitable investor with AI optimized trading strategies






×

Chat with ABUS


 Ask any question about ABUS!